Pharmacy Quality Solutions (PQS) by Innovaccer Launches EQUIPP Copilot™, Industry-First Zero-Click Intelligent Platform to Empower Pharmacies in Value-Based, Collaborative Care
SAN FRANCISCO--(BUSINESS WIRE)--May 20, 2025--
Pharmacy Quality Solutions (PQS), an Innovaccer company and leader in pharmacy-payer performance technology, today announced the launch of EQUIPP Copilot ™, the industry's first workflow-integrated intelligence platform designed to help pharmacies expand clinical services, boost productivity, and connect seamlessly with the broader healthcare ecosystem. By embedding real-time insights and automation directly into daily pharmacy operations, EQUIPP Copilot ™ redefines how pharmacists engage in value-based care, care coordination, and patient outcomes, without disrupting their workflow.
The announcement was made at the Pharmacy Quality Alliance Annual Meeting where EQUIPP Copilot ™ was introduced as the industry's first AI-enabled real-time digital copilot designed to help pharmacies participate in value-based care (VBC) and enhance operational efficiency.
'Community pharmacies are on the front lines of the value-based care evolution,' said Todd Sega, Managing Director, Pharmacy, Innovaccer. 'They face mounting pressures in the core, historical business model of dispensing medications, while needing to diversify and focus on value and patient care services in a changing payer and provider landscape. EQUIPP Copilot ™ meets this moment by delivering exactly what pharmacists need: real-time guidance and automation woven into their day-to-day workflow. It's like having a digital assistant in the pharmacy system, surfacing actionable insights and automating tasks so teams can spend more time on patients and growing revenue through clinical services.'
Pharmacies are increasingly expected to support clinical initiatives and participate in value-based care programs, but often lack the tools to do so efficiently. EQUIPP Copilot ™ solves this by embedding actionable intelligence and automation directly into their workflow, streamlining tasks, eliminating administrative burden, and enhancing patient outcomes.
Unlike standalone apps or portals, EQUIPP Copilot ™ overlays Pharmacy Management Systems (PMSs), using smart pop-ups, embedded alerts, and intelligent task automation to guide pharmacists through quality interventions at the point of care.
The key innovations of EQUIPP Copilot ™ include:
'Pharmacies are one of the most underutilized assets in value-based care,' said Abhinav Shashank, CEO of Innovaccer. 'By embedding intelligence and automation directly into their daily workflow, EQUIPP Copilot ™ turns every pharmacy into a proactive care hub. This is a key step toward a more connected, collaborative healthcare system, one where data drives smarter decisions and better outcomes at every touchpoint.'
The launch of EQUIPP Copilot ™ arrives as pharmacies face growing pressure to expand their clinical roles amid staffing constraints, shifting incentives, and the decentralization of care. The solution is purpose-built to support independent pharmacies, chains and health plans seeking scalable, real-time engagement tools.
EQUIPP Copilot ™ pre-registrations are open now with general availability in Q3 2025. The platform is offered to existing customers via a flexible freemium model, with advanced capabilities available à la carte to fit pharmacies of all sizes and needs.
About PQS by Innovaccer
PQS by Innovaccer aligns healthcare payers and pharmacies to achieve their shared goals of better patient outcomes and healthcare quality performance. As a neutral, trusted intermediary supporting the evolution of value-based care, PQS facilitates nationwide pharmacy-based care through our partners and the EQUIPP ® platform. Utilizing deep clinical pharmacy knowledge and over a decade of performance management experience, we help clients develop strategies, implement quality improvement programs, and optimize the quality of healthcare for their populations served. For more information on how PQS can support you, please visit www.pharmacyquality.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20250520903811/en/
CONTACT: Press Contact:
Arushi Awasthi
Innovaccer Inc.
[email protected]
415-562-2139
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: SOFTWARE MANAGED CARE GENERAL HEALTH PHARMACEUTICAL DATA MANAGEMENT PAYMENTS APPS/APPLICATIONS TECHNOLOGY HOSPITALS ARTIFICIAL INTELLIGENCE PRACTICE MANAGEMENT HEALTH
SOURCE: Innovaccer Inc.
Copyright Business Wire 2025.
PUB: 05/20/2025 08:15 AM/DISC: 05/20/2025 08:14 AM
http://www.businesswire.com/news/home/20250520903811/en
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
Sword Health Now Valued At $4 Billion, Announces Expansion Into Mental Health Services
Sword Health announced Tuesday that it had raised $40 million in a recent funding round, giving it a $4 billion valuation. Founded in 2015, the healthcare startup has focused on helping people manage chronic pain at home. Using AI tools, the platform connects users with expert clinicians who then provide patients with tools for digital physical therapy, pelvic health, and overall mobility health. However, the company says this new round of funding will largely go towards developing a mental health arm of its program called Mind. Don't Miss: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can "Today, nearly 1 billion people worldwide live with a mental health condition. Yet care remains fragmented, reactive, and inaccessible," Sword said in the announcement. "Mind redefines mental health care delivery with a proactive, 24/7 model that integrates cutting-edge AI with licensed, Ph.D-level mental health specialists. Together, they provide seamless, contextual, and responsive support any time people need it, not just when they have an appointment." Sword CEO Virgílio Bento told CNBC, "[Mind] really a breakthrough in terms of how we address mental health, and this is only possible because we have AI." Users will be equipped with a wearable device called an M-band, which will measure their environmental and physiological signals so that experts can reach out proactively as needed. The program will also offer access to services like traditional talk therapy. Bento told CNBC that a human is "always involved" in patients care in each of its programs, and that AI is not making any clinical decisions. Trending: Maximize saving for your retirement and cut down on taxes: . For example, if a Sword patient has an anxiety attack, AI will identify it through the wearable and bring it to the attention of a clinician, who can then provide an appropriate care plan. "You have an anxiety issue today, and the way you're going to manage is to talk about it one week from now? That just doesn't work," Bento told CNBC. "Mental health should be always on, where you have a problem now, and you can have immediate help in the moment." According to Bento, Sword Mind already has a waiting list, and is being tested by some of its partners who appreciate it's "personalized approach and convenience." "We believe that it is really the future of how mental health is going to be delivered in the future, by us and by other companies," he told CNBC. "AI plays a very important role, but the use of AI — and I think this is very important — needs to be used in a very smart way." The rest of the cash raised in the funding round, which was led by General Catalyst, will go towards acquisitions, global expansion, and AI development, Sword Health says. Read Next: Here's what Americans think you need to be considered Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? APPLE (AAPL): Free Stock Analysis Report TESLA (TSLA): Free Stock Analysis Report This article Sword Health Now Valued At $4 Billion, Announces Expansion Into Mental Health Services originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12 minutes ago
- Yahoo
Top Cryptocurrencies Fall; Bitcoin Hovers Above $103,000
Major digital assets fell Friday with Bitcoin (BTC-USD) hovering above $103,000. The CoinDesk Mar Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
15 minutes ago
- Yahoo
Top economist who previously sounded the alarm on tariffs sees a possible scenario where Trump ‘outsmarted all of us'
Torsten Sløk, chief economist at Apollo Global Management, laid out a potential scenario where President Donald Trump's tariffs are extended long enough to ease economic uncertainty while also providing a significant bump to federal revenue. That comes as the 90-day pause on Trump's 'reciprocal tariffs' is nearing an end. Businesses and consumers remain in limbo over what will happen next with President Donald Trump's tariffs, but a top economist sees a way to leave them in place and still deliver a 'victory for the world.' In a note on Saturday titled 'Has Trump Outsmarted Everyone on Tariffs?', Apollo Global Management Chief Economist Torsten Sløk laid out a scenario that keeps tariffs well below Trump's most aggressive rates long enough to ease uncertainty and avoid the economic harm that comes with it. 'Maybe the strategy is to maintain 30% tariffs on China and 10% tariffs on all other countries and then give all countries 12 months to lower non-tariff barriers and open up their economies to trade,' he speculated. That comes as the 90-day pause on Trump's 'reciprocal tariffs,' which triggered a massive selloff on global markets in April, is nearing an end early next month. The temporary reprieve was meant to give the U.S. and its trade partners time to negotiate deals. But aside from an agreement with the U.K. and another short-term deal with China to step back from prohibitively high tariffs, few others have been announced. Meanwhile, negotiations are ongoing with other top trading partners. Trump administration officials have been saying for weeks that the U.S. is close to reaching deals. On Saturday, Sløk said extending the deadline one year would give other countries and U.S. businesses more time to adjust to a 'new world with permanently higher tariffs.' An extension would also immediately reduce uncertainty, giving a boost to business planning, employment, and financial markets. 'This would seem like a victory for the world and yet would produce $400 billion of annual revenue for US taxpayers,' he added. 'Trade partners will be happy with only 10% tariffs and US tax revenue will go up. Maybe the administration has outsmarted all of us.' Sløk's speculation is notable as he previously sounded the alarm on Trump's tariffs. In April, he warned tariffs have the potential to trigger a recession by this summer. Also in April, before the U.S. and China reached a deal to temporarily halt triple-digit tariffs, he said the trade war between the two countries would pummel American small businesses. More certainty on tariffs would give the Federal Reserve a clearer view on inflation as well. For now, most policymakers are in wait-and-see mode, as tariffs are expected to have stagflationary effects. But a split has emerged. Fed Governor Christopher Waller said Friday that economic data could justify lower interest rates as early as next month, expecting only a one-off impact from tariffs. But San Francisco Fed President Mary Daly also said Friday a rate cut in the fall looks more appropriate, rather than a cut in July. Still, Sløk isn't alone in wondering whether Trump's tariffs may not be as harmful to the economy and financial markets as feared. Chris Harvey, Wells Fargo Securities' head of equity strategy, expects tariffs to settle in the 10%-12% range, low enough to have a minimal impact, and sees the S&P 500 soaring to 7,007, making him Wall Street's biggest bull. He added that it's still necessary to make progress on trade and reach deals with big economies like India, Japan and the EU. That way, markets can focus on next year, rather near-term tariff impacts. 'Then you can start to extrapolate out,' he told CNBC last month. 'Then the market starts looking through things. They start looking through any sort of economic slowdown or weakness, and then we start looking to '26 not at '25.' This story was originally featured on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
